The Elite Investment Gap
Imagine you could see what a group made up of the 1,500 people closest to ultimate executive power in the U.S. invested in. Imagine that, within the same sector, 95 of them chose to buy shares in one company, but only 3 chose to buy in another. Which of those stocks would you say was the safer bet? Which of these companies is more likely to be going somewhere good any time soon? These are the people with some of the best access to inside information on potential legal and regulatory changes. Would you bet against them?
External link. We are not responsible for the content.
Read more βMore From Psychedelic Overground
What should I look for in a psychedelic training course?
As psychedelic therapeutic practices move towards above-ground legal practice and underground psychedelic use increa...
Psychedelic-Assisted Therapy and Health Insurance in Australia
Earlier this year, Medibank, Australiaβs largest private health insurer, announced a scheme where they dedicated $10...
Soft Furniture, Psychedelic Patents, and Compass Pathways
So, apparently Compass Pathways, or in this case Compass Pathfinder Limited, are still doing the whole trying to pat...
Latest News
The Personalities Psychedelics Reward (And Punish)
Welcome to The Psychedelic Blog.
So, the Medicine Introduced You to Your Soulmate. Now What?
Meeting your soulmate in ceremony was the mystical part, but how do you make it last afterwards? [...] Read More... T...
Is Getting High Off of Banana Peels a Thing?
Congress really did try to regulate banana peels. [...] Read More... The post Is Getting High Off of Banana Peels a T...
Hashish Adventures in the Sixties
Review of Pipe Dreams and Smoke Screens (2025) by Richard Halford
FDAβs New Psychedelic Guidance Signals a Maturing Industry. Now Comes the Hard Part.
For years, the psychedelic medicine industry has operated in largely uncharted regulatory territory. Companies develo...
From βjust say noβ to just say nothing: 5 Questions for harm reduction educator Rhana Hashemi
Hashemi discusses her approach to drug education and what students want to know about psychedelics.